arrow
Back
L

Lon S. Schneider

university of southern california

86H-index
516Paper Count
5.7WCitation Count
Published Papers 132
Publication Date
Beyond symptom improvement: transdiagnostic and disorder-specific ways to assess functional and quality of life outcomes across mental disorders in adults
err2025-09-15
err0
errOAAI
errChristoph U. Correll; Samuele Cortese; Marco Solmi; Tommaso Boldrini; Koen Demyttenaere; Katharina Domschke; Paolo Fusar-Poli; Philip Gorwood; Philip D. Harvey; Richard S.E. Keefe; Christine Knaevelsrud; Roman Kotov; Laura Nohr; Taeho Greg Rhee; David Roe; Matthias Rose; Lon S. Schneider; Mike Slade; Dan J. Stein; Charlene Sunkel; Roger S. McIntyre
errShare
errSave
Clinical progression on CDR-SB©: Progression-free time at each 0.5 unit level in dominantly inherited and sporadic Alzheimer's disease populations
err2025-09-05
err0
errOAAI
errGuoqiao Wang; Yan Li; Eric McDade; Chengjie Xiong; Sarah M. Hartz; Randall J. Bateman; John C. Morris; Lon S. Schneider; for the Alzheimer's Disease Neuroimaging Initiative
errShare
errSave
Automatic detection of arterial input function for brain DCE-MRI in multi-site cohorts
err2025-08-13
err0
PREAI
errLucas Saca; Raghav Gaggar; Ioannis Pappas; Tammie Benzinger; Eric M. Reiman; Mark S. Shiroishi; Elizabeth B. Joe; John M. Ringman; Hussein N. Yassine; Lon S. Schneider; Helena C. Chui; Daniel A. Nation; Berislav V. Zlokovic; Arthur W. Toga; Ararat Chakhoyan; Samuel Barnes
errShare
errSave
High precision and cost-effective multiplex quantification of amyloid-β40, amyloid-β42, p181Tau, p217Tau, neurofilament light chain, and glial fibrillary acidic protein from plasma and serum
err2025-05-13
err0
PREAI
errAlishahi, Farshad; Beam, Christopher R.; Gatz, Margaret; Schneider, Lon S.; Nation, Daniel A.; Yassine, Hussein N.; Kaplan, Hillard; Ganesan, Suchita; Pappas, Ioannis; Davis, Deborah Winders; Zandi, Ebrahim
errShare
errSave
The science does not yet support regulatory approval of amyloid-targeting therapies for Alzheimer's disease based solely on biomarker evidence
err2025-04-17
err0
errOAAI
errPlanche, V; Schindler, S; Knopman, DS; Frisoni, G; Galasko, D; Grill, JD; Schneider, L; Karlawish, J; Villain, N
errShare
errSave
Escitalopram for agitation in Alzheimer's dementia: a randomized controlled phase 3 trial
err2025-03-25
err0
PREAI
errRajji, Tarek K.; Baksh, Sheriza N.; Shade, David M.; Ismail, Zahinoor; Burhan, Amer M.; Okhravi, Hamid R.; Padala, Prasad R.; Rosenberg, Paul B.; Schneider, Lon S.; Porsteinsson, Anton P.; Lyketsos, Constantine G.; S-CitAD Res Grp
errShare
errSave
Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer's disease
err2025-02-15
err0
errOAAI
errDavis, Miyah R.; Robinson, Edward; Koronyo, Yosef; Salobrar-Garcia, Elena; Rentsendorj, Altan; Gaire, Bhakta P.; Mirzaei, Nazanin; Kayed, Rakez; Sadun, Alfredo A.; Ljubimov, Alexander V.; Schneider, Lon S.; Hawes, Debra; Black, Keith L.; Fuchs, Dieu-Trang; Koronyo-Hamaoui, Maya
errShare
errSave
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
errLANCET
IF88.5
err2024-08-01
err86
PREAI
errLivingston, Gill; Huntley, Jonathan; Liu, Kathy Y.; Costafreda, Sergi G.; Selbaek, Geir; Alladi, Suvarna; Ames, David; Banerjee, Sube; Burns, Alistair; Brayne, Carol; Fox, Nick C.; Ferri, Cleusa P.; Gitlin, Laura N.; Howard, Robert; Kales, Helen C.; Kivimaki, Mika; Larson, Eric B.; Nakasujja, Noeline; Rockwood, Kenneth; Samus, Quincy; Shirai, Kokoro; Singh-Manoux, Archana; Schneider, Lon S.; Walsh, Sebastian; Yao, Yao; Sommerlad, Andrew; Mukadam, Naaheed
errShare
errSave
Prevalence and Impact of Bypassing or Overriding Phase 2 Trials in Neurologic Drug Development
err2024-07-09
err0
PREAI
errMoyer, Hannah; Mellett, Robyn; Vigneault, Karine; McKeown, Maya; Karlawish, Jason; Augustine, Erika; Schneider, Lon; Kimmelman, Jonathan
errShare
errSave
Novel measures of cognition and function for the AD spectrum in the Novel Measures for Alzheimer's Disease Prevention Trials (NoMAD) project: Psychometric properties, convergent validation, and contrasts with established measures
err2024-07-04
err1
errOAAI
errKim, Hyun; Lee, Seonjoo; Levine, Alina; Huber, Benjamin; Andrews, Howard; Kerner, Nancy A.; Cohen, Daniel; Carlson, Scott; Bell, Sophie A.; Rivera, Andres M.; Gordon, Marc L.; Simoes, Sabrina; Devanand, Davangere. P.; Brickman, Adam M.; Schneider, Lon S.; Harvey, Philip D.; Goldberg, Terry E.
errShare
errSave
Statistical considerations when estimating time-saving treatment effects in Alzheimer's disease clinical trials
err2024-06-21
err0
errOAAI
errWang, Guoqiao; Cutter, Gary; Oxtoby, Neil P.; Shan, Guogen; Wang, Whedy; Mangal, Brian; Liao, Yijie; Llibre-Guerra, Jorge J.; Li, Yan; Xiong, Chengjie; Mcdade, Eric; Delmar, Paul; Bateman, Randall J.; Schneider, Lon
errShare
errSave
Comparison of relative change with effect size metrics in Alzheimer's disease clinical trials
err2023-11-18
err8
errOAAI
errGoldberg, Terry E.; Lee, Seonjoo; Devanand, Davangere P.; Schneider, Lon S.
errShare
errSave
Allopregnanolone as a Regenerative Therapeutic for Alzheimer's Disease (AD): A phase 2 proof-of-concept clinical trial using hippocampal volume as a surrogate endpoint
err2023-04-25
err0
PREAI
errRivera, Gerson Hernandez; Lopez, Claudia; Raikes, Adam; Rodgers, Kathleen; Matthews, Dawn; Schneider, Lon; Brinton, Roberta
errShare
errSave
errShare
errSave
The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de-risk trial programmes of novel agents
err2023-01-14
err55
errOAAI
errCorrell, Christoph U.; Solmi, Marco; Cortese, Samuele; Fava, Maurizio; Hojlund, Mikkel; Kraemer, Helena C.; McIntyre, Roger S.; Pine, Daniel S.; Schneider, Lon S.; Kane, John M.
errShare
errSave
Proportional constrained longitudinal data analysis models for clinical trials in sporadic Alzheimer's disease
err2022-04-05
err8
errOAAI
errWang, Guoqiao; Liu, Lei; Li, Yan; Aschenbrenner, Andrew J.; Bateman, Randall J.; Delmar, Paul; Schneider, Lon S.; Kennedy, Richard E.; Cutter, Gary R.; Xiong, Chengjie
errShare
errSave
A Polymorphism Cluster at the 2q12 locus May Predict Response to Piromelatine in Patients with Mild Alzheimer's Disease
err2022-04-01
err10
PREAI
errSchneider, L. S.; Laudon, M.; Nir, T.; Caceres, J.; Ianniciello, G.; Capulli, M.; Zisapel, N.
errShare
errSave